Acino Sustainability Profile
Acino, officially known as Acino Pharma AG, is a prominent player in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 2007, the company has rapidly expanded its operations across Europe, the Middle East, and Africa, establishing a strong presence in these key regions. Acino focuses on developing and manufacturing high-quality generic and specialty pharmaceuticals, with a particular emphasis on innovative drug delivery systems. Their unique approach to formulation and packaging sets them apart in a competitive market. With a commitment to improving patient outcomes, Acino has achieved significant milestones, including numerous product launches and strategic partnerships. The company is recognised for its robust portfolio and dedication to quality, positioning it as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Acino's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Acino's score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Acino's reported carbon emissions
In 2023, Acino reported significant carbon emissions, totalling approximately 5,047,200 kg CO2e for Scope 1 and 3,209,000 kg CO2e for Scope 2 globally, amounting to a combined total of about 8,256,500 kg CO2e. In Switzerland, where its headquarters is located, Scope 1 emissions were approximately 2,787,000 kg CO2e, with no reported Scope 2 emissions. Acino is committed to achieving carbon neutrality by 2050, focusing on both Scope 1 and Scope 2 emissions. In 2023, the company initiated efforts to better understand its emissions profile and implement activities aimed at reaching this long-term goal. The emissions data is cascaded from Acino International AG, reflecting the company's commitment to sustainability within its corporate family. Acino's proactive approach to climate commitments positions it as a responsible player in the pharmaceutical industry, aligning with global climate action initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 5,047,200 |
| Scope 2 | 3,209,000 |
| Scope 3 | - |
How Carbon Intensive is Acino's Industry?
How Carbon Intensive is Acino's Location?
Acino's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Acino has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
